| 101 |
25025963 | Phase I study of olaparib in combination with liposomal doxorubicin in patients with advanced solid tumours. | 2014 Aug 12 |
1 |
| 102 |
25302077 | Evolutionarily conserved genetic interactions with budding and fission yeast MutS identify orthologous relationships in mismatch repair-deficient cancer cells. | 2014 |
1 |
| 103 |
23239809 | Synergistic effect of olaparib with combination of cisplatin on PTEN-deficient lung cancer cells. | 2013 Feb |
1 |
| 104 |
23415752 | BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation. | 2013 Jun |
1 |
| 105 |
23570906 | Identification of miRNA modulators to PARP inhibitor response. | 2013 Jun 1 |
1 |
| 106 |
23847380 | Olaparib shows promise in multiple tumor types. | 2013 Jul |
1 |
| 107 |
23966292 | EGFR-activating mutations correlate with a Fanconi anemia-like cellular phenotype that includes PARP inhibitor sensitivity. | 2013 Oct 15 |
1 |
| 108 |
22562176 | Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option. | 2012 Jul |
2 |
| 109 |
22915752 | PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition. | 2012 Nov |
1 |
| 110 |
22933245 | Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells. | 2012 Oct |
1 |
| 111 |
22987487 | HER2 overexpression renders human breast cancers sensitive to PARP inhibition independently of any defect in homologous recombination DNA repair. | 2012 Sep 15 |
1 |
| 112 |
21600381 | Novel agents and future directions for refractory breast cancer. | 2011 Jun |
1 |
| 113 |
20922827 | Targeted therapies: PARP inhibitor olaparib is safe and effective in patients with BRCA1 and BRCA2 mutations. | 2010 Oct |
1 |
| 114 |
20976249 | Role for the mammalian Swi5-Sfr1 complex in DNA strand break repair through homologous recombination. | 2010 Oct 14 |
1 |
| 115 |
19589159 | Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes. | 2009 |
1 |